Sight Sciences, Inc. (SGHT) stock
SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30174% above fair value
$10.77+0.28 (+2.67%)
Close on Nov 18, 2026Market cap $593.30MP/E –Yield –
Sight Sciences r&d expenses
Research and development expenses are spending on new products and technology.
Sight Sciences's R&D Expenses for the twelve months ending Jun 30, 2026 was $10.85M, down 39.3% year over year. For fiscal 2025 it was $14.61M, down 18.8% from the year before. The highest annual figure on record is $22.86M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.61M | -18.8% |
| FY2024 | Dec 31, 2024 | $17.99M | +2.5% |
| FY2023 | Dec 31, 2023 | $17.56M | -23.2% |
| FY2022 | Dec 31, 2022 | $22.86M | +46.2% |
| FY2021 | Dec 31, 2021 | $15.63M | +76.2% |
| FY2020 | Dec 31, 2020 | $8.87M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.51M | -42.7% |
| Q1 FY2026 | Mar 31, 2026 | $2.55M | -42.5% |
| Q4 FY2025 | Dec 31, 2025 | $2.44M | -43.2% |
| Q3 FY2025 | Sep 30, 2025 | $3.35M | -29.4% |
| Q2 FY2025 | Jun 30, 2025 | $4.39M | +1.6% |
| Q1 FY2025 | Mar 31, 2025 | $4.43M | -4.4% |
| Q4 FY2024 | Dec 31, 2024 | $4.29M | +25.3% |
| Q3 FY2024 | Sep 30, 2024 | $4.75M | +12.0% |
| Q2 FY2024 | Jun 30, 2024 | $4.32M | -17.3% |
| Q1 FY2024 | Mar 31, 2024 | $4.64M | -0.7% |
| Q4 FY2023 | Dec 31, 2023 | $3.43M | -34.5% |
| Q3 FY2023 | Sep 30, 2023 | $4.24M | -30.0% |
| Q2 FY2023 | Jun 30, 2023 | $5.22M | -11.9% |
| Q1 FY2023 | Mar 31, 2023 | $4.67M | -17.3% |
| Q4 FY2022 | Dec 31, 2022 | $5.23M | +19.8% |
| Q3 FY2022 | Sep 30, 2022 | $6.05M | +41.5% |
| Q2 FY2022 | Jun 30, 2022 | $5.93M | +67.1% |
| Q1 FY2022 | Mar 31, 2022 | $5.65M | +64.1% |
| Q4 FY2021 | Dec 31, 2021 | $4.37M | +52.1% |
| Q3 FY2021 | Sep 30, 2021 | $4.28M | +98.3% |
| Q2 FY2021 | Jun 30, 2021 | $3.55M | +145.7% |
| Q1 FY2021 | Mar 31, 2021 | $3.44M | – |
| Q4 FY2020 | Dec 31, 2020 | $2.87M | – |
| Q3 FY2020 | Sep 30, 2020 | $2.16M | – |
| Q2 FY2020 | Jun 30, 2020 | $1.44M | – |
See a number that looks wrong?